In a melanoma orthotopic mouse model, Trpa1−/− mice showed higher CD8+ T-cell activation and tumor infiltration as well as lower tumor progression than Trpa1+/+ animals [152], indicating that TRPA1 diminishes CD8+ T-cell cytotoxicity. This evidence concerns the gene TRPA1 and melanoma.